{"ticker": {"uuid": "5ec58511-344e-465d-a8c6-0779fb8d876a", "symbol": "6570", "name": "Kyowa Corporation", "exchange": "JPX", "country": "JP", "sector": "Consumer Cyclical", "industry": "Leisure"}, "articles": [{"title": "Kyowa Kirin Co Ltd (4151) Stock, Price, News, Quotes, Forecast and Insights | MSN Money", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPS0M5cUUzelU5SjVOTHdIMHp6cmpmTUt4dk1paGpqenRRUnJRdkJxcjNnWWlBSnp2WVMtdXNCSXJTN3V6OFdHWEVWT0RPZGd6RHdORGJiMmhCX2QydVRtaldJNjlXMkE1ckZocHhvai1DNW1UUGtqQXZYTEswa0lwZ1g5THdoOTJDTVV0cA?oc=5", "source_name": "MSN", "published_at": "2026-07-14T11:38:37+00:00", "published_display": "14 Jul 2026 11:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa Kirin Co Ltd (4151)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNQktuX2N2MEhtWWw0RDBqX0R2WEFiM21fcGRFeTNpb3h3MkpwYnZodTQyRDhqeWRLb1JJeFlQUjcxa2M4VFpkVjJHbkdwTjVEMnNRZDRoUlZMZ1pRcWNMVURIUHI2MUZod0V6QjVBSEZlYXpCaVlNbWxvTFhZUlRxeFM1ZHdqSk5CSVlqcUVxS2J3dw?oc=5", "source_name": "MSN", "published_at": "2026-07-14T06:09:02+00:00", "published_display": "14 Jul 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa Kirin outlines growth path as specialty pharma focus deepens", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOMm1QQ0V5aGNjdkR1OXBJNTh6MDNlQ3RyOU1TZk9RamxCZVFBOEVnd1pHWmNjVlktSjdUU0d6cU9Td3dWeF9JV1g1MUpjTXA3UHptX0Ixenh1ZEgtX0N0c0pEcWE4NFhvRElvN0s1LVpoc3lLYkNaRi1DUUtwdmxNRXZ3cG83eDM0ZVBVTlZqQ2hIcHdvakREOHpzZW1KdmowQUJSSTMwSHEzMVN0X3BwN0JYNGFQY1JfUms0YXZ5aktVSDg?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Kyowa Corporation Co. Ltd. \u2013 TSE:6570", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOck9sS3hpcFFkTkNyZkhBYkx0bjJlTGdTb0o2aFo2Vzd0RElwcW5jQl8wS3ZNMkxUSEk3eWxLSERzXzNzMzZ5ekdlTTNyUXRYM3VfRHNBWlF2WXZpcG9JS2hzcHllck45bE1HQnVVUDFJckhKT3M5eENiTk5zMHVzQUhNOGh0cmZHR1Nsam9JVHJ6NGpBTFF1V2Jqb3dTUVZoRU1fai1pZTI?oc=5", "source_name": "TradingView", "published_at": "2026-06-26T21:47:31+00:00", "published_display": "26 Jun 2026 21:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPMTJYalJzTmlMUDJRRjZYVTZ3M2NEMnpxOWVNeFUtQ2N2RDNUX2xScHV1Rk1PSzVHVFFJT3J2WHgteDFzdHBoazhFV1YxWGx1d3ZrTndtMG5PaUpvQ083UGVoTWNIUUlCLWJoelNDZV9sekE3V2E1TkstUV9IYjVNYWhVRG55OUZjVXVRdGx5NVlDYy1oU3pJamFvd0l1UGVDVnkwLUl3?oc=5", "source_name": "Market source", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa Kirin discontinues rocatinlimab trials due to safety issues", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNZlBObm92VTB2NVRKRVp4OEFlaGpSelNWWXg5TGs3c29XMktoN0xOQ3RUZHNaWVJCMmdJVTdieUlSb05TbmZBTkpqdzFyMkp5MWRrdE5QLUhsNzFjRml3TXRXTVFNNDkwRWhpLS1oTXIwNVdGcW96LVlLMFV6Z2FOSWJ4QTFtdzdVSlRIVWtLa19HNjFfMWY4R2lBdVV1bUVWcU5mSEdSNzQydw?oc=5", "source_name": "BioWorld News", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lupin enters into agreement to divest its stake in Kyowa to Unison - Lupin | Press Release", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQQ0tQMmxISjctUGFGS3hjckFpY1phek1zSlNlRE8tTS1ZckdNUG0yUlU4V2xqc3JxVmNUMXdaSlB2TUhxT2I4bTdCUC1lZ1h4bkNMRVMzLXhmUng3VHpoOVkzS0xRMWRYSDMtUll0SnpGVHU4T01oaE5xdmRGUW5XeW9rSTc2ME9CYkNORXgzVEJ2SXRZV3ZDWlRITG1KZnJFX3Rhc1ZRWEtYSVZjNWc?oc=5", "source_name": "lupin.com", "published_at": "2026-02-07T20:04:51+00:00", "published_display": "07 Feb 2026 20:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa's bet on Kura pays off as partners' oral med for AML subset wins FDA approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNWjRqdTdlWmhYUHBnWXg2VjhZQVV1aTdBdm9FaVlqUEVyR05BSHFpcXJkQTZNMHF2T1RRcHd6cGRoa2JwemoxWWJFRHlMczR2aWJDRmZ6cE1YVktFRFJISzI2YXluWGtRS3hreU1NbnEwSzJoYjBBRERyMTlwdGpPTTZDajdiUnBtbEp3TkdYY291aWhQbU56cS1EM3FJT01Xb3FOZE42dUo3aHlwb1p4YjVTcXg3UVZCYzlfU1ZUWWpFQQ?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US FDA approves Kura-Kyowa's blood cancer therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPY3ZZQVFvT0Iya2xMU3lqWHM2bzVJYVBUNnhtX2M1Vnc1bTdsdnlzSTYwZlB5MDJvaU5tZWNRbFpSbzlXNmNMUHlqbnpmaGl5OXRKOHdKWGF4aGVabjVGVno0VlRDMjN2SGVmSS1pRndRRVNXLU9zNGstSUFOY2ZPWjVhWU5ZQTkzemp6S1VyYXBJaDJzcHdnRGRNZnZCR0FhTTVIcFFMSGZnczlHVm10SGljS0lKMmJsc2xxQkN6ekg?oc=5", "source_name": "Reuters", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugJBVV95cUxOUXB6UnZBT3NxalBqQVZPV2poUjRrazJvTEt5UW5QUzVqVUNYMUFXdjViMU1CWlpYQVdQOUNkbjh0MllHc1ZtaS1aTmUyRXZoNWhzU0V3bkVDeGhydTJhMDFMaUVMZnljTnkwTnFZUmVzRnRkV1RKOTVBbXRSdEwyWUpQWmtqVUstS3Vza1RyWklJNTFhb0VEc0gtTDhyR0NwWkhsOFdrQUpTMUZLTG5pUjBVZGlvN0N6VXlNVUtQSzBXVXJPdy1FdGlWNjRKVDNvSmFIMWtULWtsbk8tSWtUTFROdlh4UGg4bnpIT2ZMUHFmOEdSbGRRNVJ2R2paZC1qMUFzLVByTmg1WmFURHZ5d2J6d29DMnF6bkprVzVSclVpc1AwTjFDbHNZS0lGRjNwcFVqTkZiekpFUQ?oc=5", "source_name": "PR Newswire", "published_at": "2025-09-08T07:00:00+00:00", "published_display": "08 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa Kirin constructs drug manufacturing facility in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTFAxMW1hWkRtSmZQQ0RXR3hvOGJNU1BqVWZmZGFnZFdMMTZUNHRXUG5yRmQ3TXpNcG5uQXVOd2JhWlAteWpiWWRVNG1TT3dJaExyNzQwUlRVd0FPQnR6MWlYWndSWnJadGtSVXQ0eWZTX2dHRkNBWVZSZG43VjRyLWc?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2025-04-14T07:00:00+00:00", "published_display": "14 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa Kirin bolsters biomanufacturing footprint with $118m Japan plant", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNNkd5cXhlSjFXd3NjYmFPM1lKZDZIbkgtYjlMYlNTYjRDRnJJc002Z0oxUzM2SUM5VnI5M0c3N0NzTU1nQXVqaTZUT0J5T21GcHdvUi0ydUFFYWlqeW5Lb3p1c1FhcVdmMkVmWHpRZ0Y5TFhuQlczRVFpMXRBMkx4MDVRMEFvbDY0VFNEU2xWNi01M2NteGQ2Rm1NdkVzVE5xc3NDaWdLRzNsNm4wS2YzdVBiQU5xZUthSk44RA?oc=5", "source_name": "BioProcess International", "published_at": "2025-04-11T07:00:00+00:00", "published_display": "11 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS", "summary": "", "url": "https://news.google.com/rss/articles/CBMingJBVV95cUxObHRFdHZSN21SQmZURXctcWo0aVpUOWJsUTZRd3I5blduZktLVzNnNk8zU0lsU3RraUMxLXVoaHRSNnNRX05HRjRKSFY3QTRIWU1kSzIyTzZoVnVGRXg2VFJlVWVKdG1QSEVQNUUyVG16Um9qSWotWFFhb0htQnRyZ3RGOVBuU0d5ODJPalFHTmZGcnRPNmpNaUhFNjR4THdQV192R3NuYWpVdUF4S2pKaEZKS3FaanBVaVM2bGduUUhjOXN0X2ZxYVNINlBYVzVVMDAzcFdHOHh3WTJTMURVaG5qMXBpVW5uRXFoMHNLUllXdlFXMnB4cHNuTG9Mdm9vd2paVlBtSm95X3RvT2k0YTJwc1pXWjNPSFJsbmVR?oc=5", "source_name": "PR Newswire", "published_at": "2025-03-08T08:00:00+00:00", "published_display": "08 Mar 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchard sells to Kyowa Kirin in gene therapy buyout", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNa0Z5M3pZTTc2VHpTb2htcmQtVVNxQUdXd1dDa2pkc3ZJQzBBOUhxM2t6LVdpYjJBVzRFdkwyam94ZFp5OUMzMHJISEJFRE0xNnpVaFVKbFphODYwUm9SUUtPWU9tS09vYm9uQjZ3eEkxbENZWm1tbmF5QTFacmlPeDE4V1dxYzNBVU54UGxNRURrNm9ZU193?oc=5", "source_name": "BioPharma Dive", "published_at": "2023-10-05T07:00:00+00:00", "published_display": "05 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa Kirin to acquire Orchard Therapeutics, maker of gene therapy Libmeldy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5nWDFxTzc3LXdiMVV3UktqZnpVY1VVSjRRdTJ2d0pIWGttZm5fdWt5WXFxRjRIZWJIemNrSmNXZ2FraFRWalBKTVNlSFdBd3h1R2Fya3dJMFhuY0FfMi1TWXdpSmdhODg?oc=5", "source_name": "STAT", "published_at": "2023-10-05T07:00:00+00:00", "published_display": "05 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Kyowa Kirin Co Ltd (4151) Stock, Price, News, Quotes, Forecast and Insights | MSN Money", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPS0M5cUUzelU5SjVOTHdIMHp6cmpmTUt4dk1paGpqenRRUnJRdkJxcjNnWWlBSnp2WVMtdXNCSXJTN3V6OFdHWEVWT0RPZGd6RHdORGJiMmhCX2QydVRtaldJNjlXMkE1ckZocHhvai1DNW1UUGtqQXZYTEswa0lwZ1g5THdoOTJDTVV0cA?oc=5", "source_name": "MSN", "published_at": "2026-07-14T11:38:37+00:00", "published_display": "14 Jul 2026 11:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa Kirin Co Ltd (4151)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNQktuX2N2MEhtWWw0RDBqX0R2WEFiM21fcGRFeTNpb3h3MkpwYnZodTQyRDhqeWRLb1JJeFlQUjcxa2M4VFpkVjJHbkdwTjVEMnNRZDRoUlZMZ1pRcWNMVURIUHI2MUZod0V6QjVBSEZlYXpCaVlNbWxvTFhZUlRxeFM1ZHdqSk5CSVlqcUVxS2J3dw?oc=5", "source_name": "MSN", "published_at": "2026-07-14T06:09:02+00:00", "published_display": "14 Jul 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa Kirin outlines growth path as specialty pharma focus deepens", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOMm1QQ0V5aGNjdkR1OXBJNTh6MDNlQ3RyOU1TZk9RamxCZVFBOEVnd1pHWmNjVlktSjdUU0d6cU9Td3dWeF9JV1g1MUpjTXA3UHptX0Ixenh1ZEgtX0N0c0pEcWE4NFhvRElvN0s1LVpoc3lLYkNaRi1DUUtwdmxNRXZ3cG83eDM0ZVBVTlZqQ2hIcHdvakREOHpzZW1KdmowQUJSSTMwSHEzMVN0X3BwN0JYNGFQY1JfUms0YXZ5aktVSDg?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Kyowa Corporation Co. Ltd. \u2013 TSE:6570", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOck9sS3hpcFFkTkNyZkhBYkx0bjJlTGdTb0o2aFo2Vzd0RElwcW5jQl8wS3ZNMkxUSEk3eWxLSERzXzNzMzZ5ekdlTTNyUXRYM3VfRHNBWlF2WXZpcG9JS2hzcHllck45bE1HQnVVUDFJckhKT3M5eENiTk5zMHVzQUhNOGh0cmZHR1Nsam9JVHJ6NGpBTFF1V2Jqb3dTUVZoRU1fai1pZTI?oc=5", "source_name": "TradingView", "published_at": "2026-06-26T21:47:31+00:00", "published_display": "26 Jun 2026 21:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPMTJYalJzTmlMUDJRRjZYVTZ3M2NEMnpxOWVNeFUtQ2N2RDNUX2xScHV1Rk1PSzVHVFFJT3J2WHgteDFzdHBoazhFV1YxWGx1d3ZrTndtMG5PaUpvQ083UGVoTWNIUUlCLWJoelNDZV9sekE3V2E1TkstUV9IYjVNYWhVRG55OUZjVXVRdGx5NVlDYy1oU3pJamFvd0l1UGVDVnkwLUl3?oc=5", "source_name": "Market source", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa Kirin discontinues rocatinlimab trials due to safety issues", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNZlBObm92VTB2NVRKRVp4OEFlaGpSelNWWXg5TGs3c29XMktoN0xOQ3RUZHNaWVJCMmdJVTdieUlSb05TbmZBTkpqdzFyMkp5MWRrdE5QLUhsNzFjRml3TXRXTVFNNDkwRWhpLS1oTXIwNVdGcW96LVlLMFV6Z2FOSWJ4QTFtdzdVSlRIVWtLa19HNjFfMWY4R2lBdVV1bUVWcU5mSEdSNzQydw?oc=5", "source_name": "BioWorld News", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lupin enters into agreement to divest its stake in Kyowa to Unison - Lupin | Press Release", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQQ0tQMmxISjctUGFGS3hjckFpY1phek1zSlNlRE8tTS1ZckdNUG0yUlU4V2xqc3JxVmNUMXdaSlB2TUhxT2I4bTdCUC1lZ1h4bkNMRVMzLXhmUng3VHpoOVkzS0xRMWRYSDMtUll0SnpGVHU4T01oaE5xdmRGUW5XeW9rSTc2ME9CYkNORXgzVEJ2SXRZV3ZDWlRITG1KZnJFX3Rhc1ZRWEtYSVZjNWc?oc=5", "source_name": "lupin.com", "published_at": "2026-02-07T20:04:51+00:00", "published_display": "07 Feb 2026 20:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa's bet on Kura pays off as partners' oral med for AML subset wins FDA approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNWjRqdTdlWmhYUHBnWXg2VjhZQVV1aTdBdm9FaVlqUEVyR05BSHFpcXJkQTZNMHF2T1RRcHd6cGRoa2JwemoxWWJFRHlMczR2aWJDRmZ6cE1YVktFRFJISzI2YXluWGtRS3hreU1NbnEwSzJoYjBBRERyMTlwdGpPTTZDajdiUnBtbEp3TkdYY291aWhQbU56cS1EM3FJT01Xb3FOZE42dUo3aHlwb1p4YjVTcXg3UVZCYzlfU1ZUWWpFQQ?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US FDA approves Kura-Kyowa's blood cancer therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPY3ZZQVFvT0Iya2xMU3lqWHM2bzVJYVBUNnhtX2M1Vnc1bTdsdnlzSTYwZlB5MDJvaU5tZWNRbFpSbzlXNmNMUHlqbnpmaGl5OXRKOHdKWGF4aGVabjVGVno0VlRDMjN2SGVmSS1pRndRRVNXLU9zNGstSUFOY2ZPWjVhWU5ZQTkzemp6S1VyYXBJaDJzcHdnRGRNZnZCR0FhTTVIcFFMSGZnczlHVm10SGljS0lKMmJsc2xxQkN6ekg?oc=5", "source_name": "Reuters", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugJBVV95cUxOUXB6UnZBT3NxalBqQVZPV2poUjRrazJvTEt5UW5QUzVqVUNYMUFXdjViMU1CWlpYQVdQOUNkbjh0MllHc1ZtaS1aTmUyRXZoNWhzU0V3bkVDeGhydTJhMDFMaUVMZnljTnkwTnFZUmVzRnRkV1RKOTVBbXRSdEwyWUpQWmtqVUstS3Vza1RyWklJNTFhb0VEc0gtTDhyR0NwWkhsOFdrQUpTMUZLTG5pUjBVZGlvN0N6VXlNVUtQSzBXVXJPdy1FdGlWNjRKVDNvSmFIMWtULWtsbk8tSWtUTFROdlh4UGg4bnpIT2ZMUHFmOEdSbGRRNVJ2R2paZC1qMUFzLVByTmg1WmFURHZ5d2J6d29DMnF6bkprVzVSclVpc1AwTjFDbHNZS0lGRjNwcFVqTkZiekpFUQ?oc=5", "source_name": "PR Newswire", "published_at": "2025-09-08T07:00:00+00:00", "published_display": "08 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa Kirin constructs drug manufacturing facility in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTFAxMW1hWkRtSmZQQ0RXR3hvOGJNU1BqVWZmZGFnZFdMMTZUNHRXUG5yRmQ3TXpNcG5uQXVOd2JhWlAteWpiWWRVNG1TT3dJaExyNzQwUlRVd0FPQnR6MWlYWndSWnJadGtSVXQ0eWZTX2dHRkNBWVZSZG43VjRyLWc?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2025-04-14T07:00:00+00:00", "published_display": "14 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa Kirin bolsters biomanufacturing footprint with $118m Japan plant", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNNkd5cXhlSjFXd3NjYmFPM1lKZDZIbkgtYjlMYlNTYjRDRnJJc002Z0oxUzM2SUM5VnI5M0c3N0NzTU1nQXVqaTZUT0J5T21GcHdvUi0ydUFFYWlqeW5Lb3p1c1FhcVdmMkVmWHpRZ0Y5TFhuQlczRVFpMXRBMkx4MDVRMEFvbDY0VFNEU2xWNi01M2NteGQ2Rm1NdkVzVE5xc3NDaWdLRzNsNm4wS2YzdVBiQU5xZUthSk44RA?oc=5", "source_name": "BioProcess International", "published_at": "2025-04-11T07:00:00+00:00", "published_display": "11 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS", "summary": "", "url": "https://news.google.com/rss/articles/CBMingJBVV95cUxObHRFdHZSN21SQmZURXctcWo0aVpUOWJsUTZRd3I5blduZktLVzNnNk8zU0lsU3RraUMxLXVoaHRSNnNRX05HRjRKSFY3QTRIWU1kSzIyTzZoVnVGRXg2VFJlVWVKdG1QSEVQNUUyVG16Um9qSWotWFFhb0htQnRyZ3RGOVBuU0d5ODJPalFHTmZGcnRPNmpNaUhFNjR4THdQV192R3NuYWpVdUF4S2pKaEZKS3FaanBVaVM2bGduUUhjOXN0X2ZxYVNINlBYVzVVMDAzcFdHOHh3WTJTMURVaG5qMXBpVW5uRXFoMHNLUllXdlFXMnB4cHNuTG9Mdm9vd2paVlBtSm95X3RvT2k0YTJwc1pXWjNPSFJsbmVR?oc=5", "source_name": "PR Newswire", "published_at": "2025-03-08T08:00:00+00:00", "published_display": "08 Mar 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchard sells to Kyowa Kirin in gene therapy buyout", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNa0Z5M3pZTTc2VHpTb2htcmQtVVNxQUdXd1dDa2pkc3ZJQzBBOUhxM2t6LVdpYjJBVzRFdkwyam94ZFp5OUMzMHJISEJFRE0xNnpVaFVKbFphODYwUm9SUUtPWU9tS09vYm9uQjZ3eEkxbENZWm1tbmF5QTFacmlPeDE4V1dxYzNBVU54UGxNRURrNm9ZU193?oc=5", "source_name": "BioPharma Dive", "published_at": "2023-10-05T07:00:00+00:00", "published_display": "05 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kyowa Kirin to acquire Orchard Therapeutics, maker of gene therapy Libmeldy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5nWDFxTzc3LXdiMVV3UktqZnpVY1VVSjRRdTJ2d0pIWGttZm5fdWt5WXFxRjRIZWJIemNrSmNXZ2FraFRWalBKTVNlSFdBd3h1R2Fya3dJMFhuY0FfMi1TWXdpSmdhODg?oc=5", "source_name": "STAT", "published_at": "2023-10-05T07:00:00+00:00", "published_display": "05 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 89, "total_relevant": 15, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 14, "score": 51, "total": 15, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 5.3, "count": 9}, {"event": "earnings", "label": "Earnings", "weight": 1.65, "count": 3}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1900.0, "latest_week": "2026-07-10", "one_week_move": 1.0, "four_week_move": 17.9, "twelve_week_move": 49.6, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.533481, "market_dynamics_buy_signal": false, "relative_strength": 13.985241, "fair_value_gap": 92.7, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 52.9447, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.0% over one week, +17.9% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "MSN", "count": 2}, {"label": "PR Newswire", "count": 2}, {"label": "ad-hoc-news.de", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "Market source", "count": 1}, {"label": "BioWorld News", "count": 1}, {"label": "lupin.com", "count": 1}, {"label": "Fierce Pharma", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 15}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 9}, {"label": "Earnings", "count": 3}, {"label": "Guidance", "count": 1}, {"label": "Deals and strategy", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "15", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+1.0% over one week, +17.9% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Kyowa Kirin Co Ltd (4151) Stock, Price, News, Quotes, Forecast and Insights | MSN Money"}], "updated_at": "2026-07-17T05:52:18.908205+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}